Chinese miner Zijin gets a credit downgrade, and Fosun Pharma sells down its BioNTech stake

Chinese miner Zijin has been downgraded by Fitch after embarking on global buying spree this year, as Chinese resource companies hunting the globe for pricey strategic assets. And Fosun Pharma has sold down its stake in German mRNA vaccine maker BioNTech, banking big profits from a tie-up launched with fanfare at the start of the pandemic.